TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Adherium Ltd. ( (AU:ADR) ) has provided an update.
Adherium Limited has announced the issuance of 50 million unquoted equity securities, specifically options expiring on December 5, 2028, at an exercise price of $0.020. This move is likely to impact the company’s capital structure and could provide additional resources for its ongoing operations and strategic initiatives, potentially enhancing its market position and offering value to stakeholders.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium Limited operates in the healthcare industry, focusing on the development and distribution of digital health technologies. The company specializes in providing solutions for respiratory conditions, aiming to improve patient outcomes through innovative monitoring and management systems.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.97M
For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.